García-Granero M - Search Results

1

Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides.

Berasain C, García-Granero M, Riezu-Boj JI, Civeira MP, Prieto J, Borrás-Cuesta F. Berasain C, et al. J Hepatol. 1993 Apr;18(1):80-4. doi: 10.1016/s0168-8278(05)80013-3. J Hepatol. 1993. PMID: 7688014 Free article.

2

Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon.

Camps J, García-Granero M, Riezu-Boj JI, Larrea E, de Alava E, Civeira MP, Castilla A, Prieto J. Camps J, et al. J Hepatol. 1994 Jul;21(1):4-11. doi: 10.1016/s0168-8278(94)80129-0. J Hepatol. 1994. PMID: 7963420 Free article. Clinical Trial.

3

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

Lasarte JJ, García-Granero M, López A, Casares N, García N, Civeira MP, Borrás-Cuesta F, Prieto J. Lasarte JJ, et al. Hepatology. 1998 Sep;28(3):815-22. doi: 10.1002/hep.510280332. Hepatology. 1998. PMID: 9731578 Free article.

4

Simple strategy to induce antibodies of distinct specificity: application to the mapping of gp120 and inhibition of HIV-1 infectivity.

Prieto I, Hervás-Stubbs S, García-Granero M, Berasain C, Riezu-Boj JI, Lasarte JJ, Sarobe P, Prieto J, Borrás-Cuesta F. Prieto I, et al. Eur J Immunol. 1995 Apr;25(4):877-83. doi: 10.1002/eji.1830250403. Eur J Immunol. 1995. PMID: 7737288

5

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

Camps J, Crisóstomo S, García-Granero M, Riezu-Boj JI, Civeira MP, Prieto J. Camps J, et al. Gut. 1993 Dec;34(12):1714-7. doi: 10.1136/gut.34.12.1714. Gut. 1993. PMID: 7904252 Free PMC article.

6

Specific and general HLA-DR binding motifs: comparison of algorithms.

Borrás-Cuesta F, Golvano J, García-Granero M, Sarobe P, Riezu-Boj J, Huarte E, Lasarte J. Borrás-Cuesta F, et al. Hum Immunol. 2000 Mar;61(3):266-78. doi: 10.1016/s0198-8859(99)00153-6. Hum Immunol. 2000. PMID: 10689116 Free article.

7

Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon.

de Alava E, Camps J, Pardo-Mindán J, García-Granero M, Muñoz M, Sola J, Civeira MP, Contreras F, Vázquez JJ, Castilla A, et al. de Alava E, et al. Liver. 1993 Apr;13(2):73-9. doi: 10.1111/j.1600-0676.1993.tb00610.x. Liver. 1993. PMID: 8510490 Clinical Trial.

8

Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library.

Dotor J, López-Vázquez AB, Lasarte JJ, Sarobe P, García-Granero M, Riezu-Boj JI, Martínez A, Feijoó E, López-Sagaseta J, Hermida J, Prieto J, Borrás-Cuesta F. Dotor J, et al. Cytokine. 2007 Aug;39(2):106-15. doi: 10.1016/j.cyto.2007.06.004. Epub 2007 Sep 4. Cytokine. 2007. PMID: 17804251 Free article.

9

Interaction Among Sex, Aging, and Epigenetic Processes Concerning Visceral Fat, Insulin Resistance, and Dyslipidaemia.

Arpón A, Milagro FI, Santos JL, García-Granero M, Riezu-Boj JI, Martínez JA. Arpón A, et al. Among authors: garcia granero m. Front Endocrinol (Lausanne). 2019 Jul 17;10:496. doi: 10.3389/fendo.2019.00496. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31379754 Free PMC article.

10

A weight-loss model based on baseline microbiota and genetic scores for selection of dietary treatments in overweight and obese population.

Cuevas-Sierra A, Milagro FI, Guruceaga E, Cuervo M, Goni L, García-Granero M, Martinez JA, Riezu-Boj JI. Cuevas-Sierra A, et al. Among authors: garcia granero m. Clin Nutr. 2022 Aug;41(8):1712-1723. doi: 10.1016/j.clnu.2022.06.008. Epub 2022 Jun 16. Clin Nutr. 2022. PMID: 35777110 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters